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Abstract
Background: The zebrafish Danio rerio is an important model system for drug discovery and to
study cardiovascular development. Using a laser-scanning confocal microscope, we have developed
a non-invasive method of measuring cardiac performance in zebrafish embryos and larvae that
obtains cardiovascular parameters similar to those obtained using Doppler echocardiography in
mammals. A laser scan line placed parallel to the path of blood in the dorsal aorta measures blood
cell velocity, from which cardiac output and indices of vascular resistance and contractility are
calculated.
Results: This technique, called laser-scanning velocimetry, was used to quantify the effects of
pharmacological, developmental, and genetic modifiers of cardiac function. Laser-scanning
velocimetry was applied to analyze the cardiovascular effects of morpholino knockdown of
osmosensing scaffold for MEKK3 (OSM), which when mutated causes the human vascular disease
cerebral cavernous malformations. OSM-deficient embryos had a constricted aortic arch and
markedly increased peak cell velocity, a characteristic indicator of aortic stenosis.
Conclusion: These data validate laser-scanning velocimetry as a quantitative tool to measure
cardiovascular performance for pharmacological and genetic analysis in zebrafish, which requires
no specialized equipment other than a laser-scanning confocal microscope.
Background
The zebrafish Danio rerio are widely used in genome-wide
screens to identify genes that regulate the development
and function of the vertebrate cardiovascular system [1-3].
Zebrafish are powerful model organisms to define genes
relevant to human cardiovascular disease because of their
similarity in genetic complexity to mammals, the ease of
selective gene knockdown, and their suitability for large-
scale mutagenesis screens [4,5]. A beating heart and func-
tional circulatory system forms within 26 hours of fertili-
zation, and within 48 hours the heart develops into a two-
chambered conformation, complete with functional
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valves. Because of their transparency, severe morphologi-
cal abnormalities in cardiac development are easily
observed, but the functional consequences of these
defects are difficult to quantify. Methods are needed for
functional analysis of cardiovascular defects that can be
utilized by any investigator studying zebrafish cardiovas-
cular physiology. Using an unmodified, commercially-
available laser-scanning confocal microscope, we have
developed a novel, non-invasive method of measuring
cardiac performance in zebrafish embryos that provides
measurements similar to those obtained with Doppler
echocardiography. The technique, called laser-scanning
velocimetry provides a continuous measurement of blood
cell velocity that is necessary for estimating cardiac output
(velocity integral) and measuring indices of vascular
resistance (peak deceleration) and ventricular contractility
(peak acceleration).
We first demonstrate that laser-scanning velocimetry is a
sensitive and precise tool for measuring the physiological
changes during normal cardiovascular development and
drug-induced cardiotoxicity. We then use laser-scanning
velocimetry to evaluate the cardiovascular function of
zebrafish embryos with reduced expression of osmosens-
ing scaffold for MEKK3 (OSM) – a scaffold protein, whose
mutation in humans leads to the development of a vascu-
lar disorder called cerebral cavernous malformations [6].
Using microangiography we demonstrate that OSM mor-
phant embryos have a constricted aortic arch. Analysis by
laser-scanning velocimetry functionally verified the pres-
ence of aortic stenosis through a markedly increased peak
cellular velocity. These experiments establish laser-scan-
ning velocimetry as a simple yet powerful technique that
allows quantitative physiological analysis of cardiac per-
formance in zebrafish embryos.
Results and discussion
Linescan images depict cell flux and velocity within blood 
vessels
Linescans are images constructed with laser-scanning
microscopes by repeatedly imaging a one pixel-wide line.
Whereas traditional two-dimensional images provide spa-
tial information in both the x- and y-dimensions, lines-
cans contain spatial information in the x-dimension and
temporal information in the y-dimension. When the scan
line is placed across a vessel, either perpendicular or par-
allel to the flow of blood, the resulting linescan images
contains information about the dynamics of circulation
(Figure 1). Because images of the linear region of interest
can be acquired rapidly, linescans provide excellent tem-
poral resolution. In a perpendicular linescan image, the
width of a blood cell in the x-dimension of the image is
proportional to the physical width of the cell, whereas the
length is proportional to the time required for the cell to
cross the imaging line (Figure 1b and 1c). Faster moving
cells cross the scan line more quickly and appear to be
shorter than slower moving cells. In vessels with high cell
flux, such as the dorsal aorta, periodic changes in apparent
cell length are evident and reflect the periodic change in
cellular velocity caused by ventricular contraction and
subsequent relaxation (Figure 1c). Cell flux can easily be
determined from perpendicular linescans by simply
counting the number of cells that completely cross the
imaging line in a given unit of time.
Many diagnostic indices of cardiac function can be calcu-
lated from a continuous measurement of the velocity of
blood cells flowing through the dorsal aorta (Table 1).
While cellular velocity can be calculated from the length
of a cell in a perpendicular linescan image, cell lengths are
difficult to measure within high-flux vessels, and the
velocity calculation assumes that the cells are all spherical
and have the same dimensions. Furthermore, velocity cal-
culations based on perpendicular linescans are discontin-
uous: because each measurement represents the average
velocity for the duration of time the cell was crossing the
scan line, the instantaneous velocity of a cell is not attain-
able. These limitations are overcome using a scan line
placed parallel to the flow of blood (Figure 1d). Parallel
linescans acquired from the dorsal aorta contain a series
of lines whose slopes alternate in a sigmoidal fashion
(Figure 1d, bottom panel). These lines are created when a
high-contrast cellular feature (such as the edge of a cell)
crosses the scan line. Each scan captures the position of
these features along the line. Successively adding these
single line images together creates a linescan image where
the positions of these features in the x-dimension are
recorded as a function of time in the y-dimension. If a cell
is stationary, its position will not change along the line
and it will appear as a vertical stripe, whereas a cell mov-
ing faster than the scan speed will appear as a horizontal
streak. Thus velocity is inversely proportional to the slope
of the line traced by the cell in the linescan. Three phases
of cell traces can be observed in most parallel linescans:
convex, linear, and concave, which correspond to phases
of accelerating, constant and decelerating velocity, respec-
tively. The continuity of velocity information provided by
laser-scanning velocimetry makes it possible to measure
blood acceleration and deceleration – parameters previ-
ously only attainable using Doppler echocardiography –
that are indices of vascular resistance and contractility [7-
9].
A scan line placed in the middle of the vessel was found to
be optimal for velocimetry measurements because the flux
of cells crossing the line is much higher than at the
extreme periphery (Figure 1c, bottom panel). While blood
flow within this long artery should be laminar, significant
differences in cellular velocity were not observed as the
scan line was moved from the center of the lumen to theBMC Biotechnology 2007, 7:40 http://www.biomedcentral.com/1472-6750/7/40
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periphery. The maximum cellular velocity obtained from
a scan line placed in the middle of the lumen of a 48 hpf
embryo was 0.2459 ± 0.0102 cm/s, and that obtained
from a scan line at the periphery of cell flux was 0.2455 ±
0.0276 cm/s. The apparently constant flow profile may be
explained by the requirement of cell motion for laser-
scanning velocimetry to measure velocities. While the
plasma velocity may be lower very near the vessel wall,
velocities in this region cannot be determined by laser-
scanning velocimetry because few cells are present (Figure
1c, bottom panel).
Laser-scanning velocimetry is a sensitive technique for 
assessing drug-induced cardiotoxicity
To demonstrate that laser-scanning velocimetry is a sensi-
tive technique capable of measuring subtle differences in
cardiac performance caused by pharmacological modifi-
cation, we acquired linescans from a two day old zebrafish
embryo successively treated with increasing concentra-
tions of the aquatic anaesthetic tricaine, which is known
to suppress cardiac function at high doses. Linescans
obtained from untreated embryos and those bathed in a
cardiac-suppressing dose of tricaine (500 μM) yielded
velocity-versus-time profiles similar to those obtained by
continuous-wave Doppler echocardiography in mammals
(Figure 2a and 2b). The tricaine treatment caused a 40%
reduction of peak cell velocity from 0.25 cm/s to 0.15 cm/
s (Figure 2a and 2b). As the concentration of tricaine
increased, peak velocity decreased with a sigmoidal dose-
response relationship (Figure 2c). It has long been appre-
ciated in Doppler echocardiography that peak accelera-
tion is closely correlated with ventricular contractility
[7,10]. Acceleration of blood cells was determined from
the derivative of the velocity-versus-time profiles, and was
also decreased by tricaine (Figure 2a, b, and 2d).
Stroke volume, the volume of blood ejected by the heart
in one beat, can be determined by integrating the contin-
uous velocity versus time graphs obtained by laser-scan-
ning velocimetry and multiplying by the cross-sectional
area of the aorta. Since the heart is a pump, stroke volume
is an excellent functional measure of cardiac performance.
Estimates of stroke volume decreased significantly over a
concentration range of tricaine that caused little change in
heart rate (Figure 2e and 2f). Heart rates were found to
remain relatively steady at low to moderate doses of tric-
aine (Figure 2f). Because heart rates varied little over the
dose range tested, cardiac output decreased proportion-
ately with decreases in stroke volume (Figure 2e and 2g).
Our assessment of cardiac output by laser-scanning
velocimetry (~ 18.6 nL/min at 48 hpf) is in good agree-
ment with volume-approximating methods of estimating
cardiac output but our method is based on actual output
and does not assume normal heart morphology [11,12].
Acquring linescan images from Danio rerio embryos Figure 1
Acquring linescan images from Danio rerio embryos. 
(a) In silico microangiogram of a 48 hpf wild-type zebrafish 
embryo. Regions of interest used for acquiring linescan 
images are boxed (intersomitic vessel = ISV, dorsal aorta = 
DA). (b and c) A single plane (XY) image (Top) showing the 
orientation of scan lines used to create perpendicular lines-
cans (Bottom) of the intersomitic vessels (b) and dorsal aorta 
(c). The boundary between slow moving (elongated) cells and 
fast moving (compressed) cells reflects a ventricular contrac-
tion and is easily observed in the Dorsal Aorta (c). (d) A par-
allel linescan acquired from the dorsal aorta shows a series of 
lines whose slope is inversely proportional to cellular veloc-
ity. Distinct regions of acceleration, constant velocity, and 
deceleration are observed.BMC Biotechnology 2007, 7:40 http://www.biomedcentral.com/1472-6750/7/40
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Absolute measurements of stroke volume can be obtained
when the scan line is placed along the outflow tract prior
to any arterial branches. While it is not always possible to
image the outflow tract prior to arterial branching, an esti-
mate of stroke volume can be obtained by measuring cel-
lular velocities along the dorsal aorta immediately caudal
to the fusion of the lateral dorsal aortas (Figure 1a). Rela-
tive comparisons of stroke volume and cardiac output can
be made between embryos of the same developmental
stage when the scan line is placed in the same position
along the artery. To investigate the dependence of stroke
volume and cardiac output estimates on scan line posi-
tion, measurements were acquired along the dorsal aorta
in a rostral location (immediately caudal to the fusion of
the lateral dorsal aortas) a caudal location (above the
cloaca). When the scan line is placed in the caudal posi-
tion, peak velocity and acceleration are underestimated by
15–20% (see Additional file 1, panels a-c). Interestingly,
stroke volume and cardiac output estimates are not signif-
icantly changed when measured with either a rostral or a
caudal scan line position (see Additional file 1, panels d
and e).
Correlating structure and function in the developing heart
The two-chambered heart of Danio rerio matures into an
adult-like morphology by five days post fertilization
(dpf). We used laser-scanning velocimetry to correlate dif-
ferences in cardiac function with developmental changes
in heart structure (Figure 3). Because laser-scanning
velocimetry is non-invasive, the development of individ-
ual embryos can be followed over time. Representative
velocimetry profiles from zebrafish at 1, 2, 4, and 5 days
post fertilization are shown in Figure 3a. Changes in car-
diovascular parameters between days 1 and 5 are shown
for both a single fish and a population (Figure 3b–h).
Trends in the development of cardiovascular function
observed in individuals were representative of the changes
observed in the population, indicating the legitimacy and
reproducibility of laser-scanning velocimetry.
At day one, the zebrafish heart exists as an elongated,
primitive tube that regularly contracts but has not yet
developed into a two-chambered heart [13]. Blood is
ejected from the one day heart with gradual but rather sus-
tained changes in velocity (Figure 3a). Both acceleration
and deceleration are minimal at this stage (Figure 3d and
3e). By day two the heart has differentiated into a two-
chambered heart, has looped into its adult conformation,
and the atrio-ventricular valves have formed. Velocity-ver-
sus-time peaks for each heart beat are sharper and more
frequent than at day one (Figure 3a). Notably, by day two
there are significant increases in peak velocity and peak
acceleration, as well as in estimates of stroke volume, and
cardiac output (Figure 3b, d, g, and 3h). Peak deceleration
is an index of vascular resistance and is greatest at this
time. This increase in resistance provides enough oppos-
ing force to the forward motion of blood that some retro-
grade motion, indicated by negative minimum velocity
values, is observed (Figure 3c and 3e). After day two, vas-
cular resistance decreases and minimum velocities are
greater than zero (Figure 3c and 3e). Because there is no
reversal of flow direction, peak acceleration actually
decreases between days two and three. Thus, it should be
noted that, as in ultrasound, peak acceleration is a load-
dependent measurement and should be used as an index
of contractility only when there are no significant differ-
ences in vascular resistance.
Between days 2 and 5 changes in heart chamber orienta-
tion and differentiation continue, but no overt structural
changes occur [13]. This is reflected by only modest
changes in peak velocity, stroke volume, and cardiac out-
put between days two and five (Figure 3b–e, and 3g).
Laser-scanning velocimetry provides functional evidence 
for the presence of an aortic constriction in OSM-deficient 
embryos
It was recently shown that valentine mutant embryos have
a mutation at the ccm2/OSM locus that prevents concen-
tric patterning of the myocardium and results in a loss of
blood flow. To demonstrate that laser-scanning velocime-
try is a valuable diagnostic tool to study the functional
consequences of genetic modification of heart develop-
ment, we studied the cardiovascular phenotype of
embryos where expression of the ccm2 gene product OSM
was inhibited by morpholino suppression of translation.
Translation-blocking morpholino oligonucleotides tar-
geted at or near the translation start site of the Danio rerio
ccm2/osm mRNA were injected into embryos between the
1 and 4 cell stages. OSM protein expression in mor-
Table 1: Measured quantities, their physiological correlates and diagnostic utility
Physical Measurement Physiological Parameter Diagnostic Relevance
Peak Velocity Peak Velocity ↑ in Aortic Stenosis, ↓ in Heart Failure
Minimum Velocity Minimum Velocity Negative with valvular dysfunction
Peak Acceleration Contractility ↓ in Heart Failure
Peak Deceleration Peripheral Resistance Indicative of vascular tone and development
Velocity Integral Stroke Volume and Cardiac Output ↓ in Heart FailureBMC Biotechnology 2007, 7:40 http://www.biomedcentral.com/1472-6750/7/40
Page 5 of 11
(page number not for citation purposes)
pholino-injected embryos was reduced to nearly undetec-
table levels as demonstrated by western blotting at 48 hpf
(Figure 4a and 4b). When normalized to an ERK2 loading
control by densitometry, OSM expression was reduced by
98% relative to control embryos (Figure 4b). OSM-defi-
cient embryos had pericardial edema (Figure 4c, arrow),
and significantly reduced circulation of erythrocytes. Each
of two OSM morpholinos generated the same phenotypes
with slightly different potencies (please see Additional file
2). To show that the reduced circulation was specific for
the repression of ccm2/osm  translation, we rescued the
morphant phenotype by co-injecting in vitro transcribed
mRNA from the entire coding region of Danio rerio ccm2/
osm cDNA along with the morpholino designed to target
the 5' untranslated region of the endogenous ccm2/osm
mRNA (OSM MO#1). Quantification of cell flux using
perpendicular linescan images indicated that erythrocyte
flux in OSM-deficient embryos was reduced to 55% that
of control embryos, and this phenotype was almost com-
pletely restored by co-injection of ccm2/osm mRNA (Fig-
ure 4d)
Because homozygous null mice for ccm1/Krit1 die at E8.5
due to a constricted aortic arch [14], we investigated
whether the decreased circulation in OSM morphants was
due to defective vessel formation. In silico microangiogra-
phy was used to outline the functional vasculature in con-
trol and OSM morphant embryos. In silico
microangiography is a simple and non-invasive technique
that uses digital image processing of images obtained
using widefield microscopy and a CCD camera, and deliv-
ers results similar to laborious dye injection-based micro-
angiography methods [15]. Microangiograms of the
outflow tract of 26 hpf embryos revealed constricted flow
through the aortic arch of morphant but not control
embryos (Figure 4e). Movies of the aortic arch clearly
show erythrocytes travelling side-by-side through the arch
of a control embryo while there is only room for single-
file travel through an OSM-deficient embryo (please see
Additional file 3). Vessel patterning and lumen formation
was unaffected in other vessels (please see Additional file
2), indicating a specific defect in aortic arch patterning.
In human and veterinary cardiology, Doppler echocardi-
ography is used to diagnose aortic stenosis (constric-
tions). One characteristic change observed in patients
with aortic stenosis is an increase in peak velocity because
the constricted passage acts as a nozzle to increase the
velocity of blood flowing through it [16]. Laser-scanning
velocimetry measurements indicated that the peak cellu-
lar velocity in OSM morphants was 0.182 ± 0.019 cm/s
versus 0.076 ± 0.011 cm/s in control embryos (Figure 4f).
These results demonstrate that laser-scanning velocimetry
can be used as a diagnostic tool for studying the genetics
Laser-scanning velocimetry measures the cardiac toxicity of  tricaine Figure 2
Laser-scanning velocimetry measures the cardiac 
toxicity of tricaine. (a and b) Velocity and acceleration 
profiles acquired from the dorsal aorta of 48 hpf embryos 
untreated (a) or treated (b) with 500 μM tricaine. (c-g) Car-
diac parameters of a single Danio rerio embryo treated with 
successively increasing doses of tricaine. Dose-response rela-
tionship of peak velocity (c), peak acceleration (d), stroke 
volume (e), heart rate (f) and cardiac output (g). Error bars 
represent the SEM of values obtained from four to six heart-
beats in a single embryo. Lines are a non-linear least squares 
fit to a sigmoidal dose-response curve. Laser-Scanning 
Velocimetry Data Analyzer smoothing parameters used for 
trace, velocity, and acceleration smoothing were 5, 60, and 
80, respectively.
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Functional assessment of cardiac performance in the developing zebrafish heart Figure 3
Functional assessment of cardiac performance in the developing zebrafish heart.(a) Representative velocimetry and 
acceleration profiles from Danio rerio embryos and larvae during development. (b-h) Cardiovascular parameters measured at 1, 
2, 4 and 5 days post-fertilization from a single zebrafish (dotted line with triangles) and a population average (solid line with 
squares). (b) Peak velocity, (c) minimum velocity, (d) peak acceleration, (e) peak deceleration, (f) heart rate (no error bars are 
present for the single fish measurement because beat-to-beat variability is not calculated), (g) stroke volume, and (h) cardiac 
output. Single-fish data presented are the average obtained by analyzing four to six individual heart beats. Error bars are the 
SEM and represent intrafish variability. For population average data n = 5 for days 1, 2, and 4; n = 4 for day 5. Error bars are the 
SEM and represent interfish variability. Laser-Scanning Velocimetry Data Analyzer smoothing parameters used for trace, veloc-
ity, and acceleration smoothing were 5, 10, and 20, respectively.
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Laser-scanning velocimetry provides functional evidence for the presence of an aortic arch constriction in OSM-deficient  embryos Figure 4
Laser-scanning velocimetry provides functional evidence for the presence of an aortic arch constriction in 
OSM-deficient embryos. (a) Western blotting for OSM in lysates from control or OSM morpholino-injected embryos har-
vested at 48 hpf shows nearly complete repression of OSM expression. The abundance of ERK2 is shown as a loading control. 
(b) Intensity of OSM bands normalized to ERK2 by densitometry for western blots shown in Panel a. (c) OSM morphant 
embryos at 48 hpf exhibited pericardial edema (arrowhead). (d) Co-injection of OSM mRNA along with OSM morpholino 
restored cell flux to levels similar to that of control embryos. Cell flux was quantified by scan lines drawn perpendicular to the 
dorsal aorta above the cloaca. Error bars represent the SEM, n = 3. (e) In silico microangiography of the aortic arch (arrow-
heads) at 28 hpf shows constricted flow through this region of the outflow tract in OSM-deficient embryos. A region of post-
stenotic dilation (arrow), the result of turbulent flow, is occasionally observed. Scale bar is 25 μm. (f) Peak blood cell velocity, 
measured by laser-scanning velocimetry is increased in OSM-deficient embryos. Error bars represent SEM. Asterisk denotes p 
= 0.0017 for the two-tailed Student's T-test, n = 3. OSM morpholino #1 was used for the data presented here. Laser-Scanning 
Velocimetry Data Analyzer smoothing parameters used for trace, velocity, and acceleration smoothing were 5, 10, and 20, 
respectively.BMC Biotechnology 2007, 7:40 http://www.biomedcentral.com/1472-6750/7/40
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of cardiac performance as well as identifying genes
responsible for congenital heart diseases.
Conclusion
Despite the widespread use of zebrafish for understanding
cardiac development and function, few quantitative tools
exist to measure functional cardiovascular phenotypes in
embryos. Laser-scanning velocimetry meets this need,
using a standard laser-scanning confocal microscope for
non-invasive measures of cardiac function. High-resolu-
tion ultrasound has been used to measure cardiovascular
performance in adult zebrafish [17], and technically could
be applied to the analysis of the zebrafish embryonic car-
diovascular system. Unlike confocal microscopes that are
available at many research institutions, high-resolution
ultrasound requires expensive and highly specialized
equipment that are not generally available to many inves-
tigators. We have shown that laser-scanning velocimetry
provides sensitive and precise measures of cardiac func-
tion including contractility, cardiac output, vascular resist-
ance, heart rate, and stroke volume. Our data demonstrate
that laser-scanning velocimetry easily measures drug-
induced cardiotoxicity, performance changes during car-
diovascular development and can diagnose anatomic
lesions such as aortic stenosis in genetically-manipulated
embryos.
Laser-scanning velocimetry provides quantitative and pre-
cise measures of several indices of cardiac performance
(summarized in Table 1) and offers significant improve-
ments over existing pre-clinical cardiovascular diagnostic
techniques. A recent report by Pan, et. al. combines lines-
cans with correlation spectroscopy to measure the velocity
of cells travelling through the dorsal aorta of embryonic
zebrafish [18]. While determining velocity vectors by cor-
relation spectroscopy is a significant advance, this tech-
nique requires two sequential measurements that severely
limit its temporal resolution. Discontinuous measure-
ments of cellular velocities have been made in zebrafish
embryos using video microscopy, and in transgenic
mouse embryos expressing GFP-labeled erythrocytes
using perpendicular linescans [15,19]. Dual spot cross
correlation methods of measuring blood cell velocity have
existed since the mid-1970s and should be applicable to
measuring blood cell velocity in zebrafish embryos with
good temporal resolution [20-23]. These methods use two
photodiodes spaced a fixed distance apart along the path
of blood flow, and cell velocities are calculated based on
the time required for a cell to pass between the two detec-
tors. Because cross-correlation methods only measure the
average speed of a cell as it passes between the two detec-
tors, they do not continuously measure velocity. This con-
tinuity is required for calculating acceleration and
deceleration, which contains important information
about contractility and peripheral resistance. The use of a
parallel scan line allows us to continuously measure the
velocity of the same object so long as it is located within
the linear scanning region. This feature is what makes
laser-scanning velocimetry unique in its temporal resolu-
tion for both velocity and acceleration measurements.
Video microscopy has also been used to measure cardiac
output in Xenopus laevis, Gallus gallus, and Danio rerio
embryos [11,12,24-26]. This technique estimates the vol-
ume of blood ejected from the ventricle based on the
observed changes in its diameter. Our measurements of
cardiac output using laser-scanning velocimetry are in
good agreement with these published values [12]. While
the cardiac output measurements described here are esti-
mates that assume a circular vessel cross-section, and can
be underestimated if linescans are obtained from the aorta
after arterial branches, they do not require normal heart
morphology and valve function. A more exact determina-
tion of cardiac output may be obtained using laser-scan-
ning velocimetry in transgenic zebrafish animals where
the vessel dimensions are delineated by an endothelial
expressed GFP such as fli1-GFP [27].
Recently, the genes responsible for two mutant zebrafish
embryos that have similar cardiovascular phenotypes,
santa  and  valentine, were mapped to ccm1  and  ccm2,
respectively [28]. The valentine mutant contains a muta-
tion in OSM and exhibits pericardial edema, a dilated
heart, and a complete lack of blood flow [28]. Mor-
pholino knockdown of OSM resulted in significantly
reduced circulation relative to control zebrafish. The fact
that morpholino knockdown of OSM did not completely
inhibit blood flow is probably a result of low level OSM
expression in contrast to complete loss of functional OSM
protein in the valentine mutant.
The observation that OSM plays a role in aortic arch
lumen formation has important implications for the
pathobiology of cerebral cavernous malformations. Mice
homozygous for a gene-trap insertion of β-galactosidase
into the ccm1/Krit1 locus also have a constricted aortic
arch [14], indicating that a loss of Krit1 in mouse pheno-
copies a loss of OSM in zebrafish. When viewed in light of
evidence that OSM and Krit1 physically associate with
each other at sites of actin reorganization [29], these data
suggest that Krit1 and OSM may act as a complex to organ-
ize developmental signals required for proper aortic arch
lumen formation.
Zebrafish are a popular model for drug screens because of
their genetic similarity to humans, the speed of screening
in a physiological context and cost-effectiveness [30]. In
addition to providing a diagnostic tool for molecular
geneticists, laser-scanning velocimetry has obvious appli-
cations in pre-clinical drug development. For example,BMC Biotechnology 2007, 7:40 http://www.biomedcentral.com/1472-6750/7/40
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laser-scanning velocimetry could easily be used to identify
anti-arhythmic compounds capable of reversing the fibril-
lating phenotype of the tremblor or reggae mutants [31].
Similarly, the potency and efficacy of potential inotropic
drugs, which increase the force of ventricular contractions
in heart failure, could easily be screened in wild-type
zebrafish embryos to find those compounds that best
increase the peak acceleration of blood cells. As demon-
strated in Figure 2, in addition to supporting pre-clinical
efficacy studies, laser-scanning velocimetry can also be
used to readily identify molecules that possess cardiotox-
icity.
Laser-scanning velocimetry quantifies the effects of
genetic and pharmacological modifiers of cardiovascular
function. With the increasing popularity of zebrafish in
basic science and the pharmaceutical industry, the devel-
opment of additional techniques to correlate physiologi-
cal function with genes and their chemical modifiers
promises to accelerate drug discovery and development in
the post-genomic area.
Methods
Zebrafish husbandry
Zebrafish (Danio rerio) embryos used for velocimetry
measurements and morpholino injections were obtained
by natural spawning of a wild-type AB* line. Embryos
were raised at 28.5°C in 30% Danieau solution(17 mM
NaCl, 0.21 mM KCl, 0.12 mM MgSO4, 0.18 mM
Ca(NO3)2, 1.5 mM HEPES pH 7.6). Zebrafish were han-
dled in accordance with IACUC approved protocols.
Laser-scanning velocimetry
Embryos for imaging were placed in a 4-well coverglass-
bottom chamber slide (Lab-Tek) in 30% Danieau solu-
tion containing the anaesthetic tricaine at a final concen-
tration of 100 μg/ml or as indicated. After a three-minute
delay to ensure a steady-state level of anaesthesia, images
were captured using an Olympus Fluoview FV1000 laser-
scanning microscope with an Olympus PlanApo N (60 ×/
1.42 oil) lens using DIC optics. Scan lines were oriented
parallel to the flow of blood within the dorsal aorta, just
above the yolk ball. Approximately 15,000 lines were
acquired per sample at a rate of 0.488 ms/line allowing a
maximum velocity of 4.10 cm/s to be measured. Using a
20 μm line and the optical system described above, a min-
imum scan rate of 8 ms/line is required to record the max-
imum cellular velocity of 0.25 cm/s observed in these
experiments. Cell paths within parallel linescans were
traced using the NeuronJ plugin v.1.1.0 for ImageJ v.1.37
[32]. High-quality DIC images and proper adjustment of
NeuronJ parameters were critical to obtaining quality trac-
ings. Good results were obtained with the following Neu-
ronJ settings: Hessian smoothing scale = 1.0, cost weight
factor = 0.7, snap window size = 1 × 1, path-search win-
dow size = 800 × 800, tracing smoothing range = 10, trac-
ing subsampling factor = 1, and line width = 1. NeuronJ
trace coordinates were exported as text files then proc-
essed to calculate average velocity and acceleration versus
time data with Laser-Scanning Velocimetry Data Analyzer
software we developed using Visual Basic v6.0 and Access
2003 (Microsoft). Briefly, the position versus time data
exported from NeuronJ was smoothed using a moving
average function. The instantaneous slope of this
smoothed trace was determined for each time point.
Where multiple traces were measured for a single point in
time, the calculated velocities were averaged. Acceleration
data were obtained from the instantaneous slope of veloc-
ity-versus-time profiles. A moving average function was
used throughout the calculation workflow to minimize
noise. The interval of the moving average can be specified
as smoothing factors in the data analyzer software. Higher
smoothing factors will underestimate measured values
but will increase precision. Data are only comparable
when calculated using the same smoothing factors and
have been specified in the figure legends.
Tricaine dose-response treatment
A single zebrafish embryo at 30 hpf was placed in a cover-
glass-bottom chamber slide containing 30% Danieau
solution without tricaine. Parallel linescans were acquired
from the free-floating, non-anesthetized embryo to obtain
baseline values of an untreated embryo. After a baseline
image was collected, the 30% Danieau was sequentially
replaced with 30% Danieau solutions containing increas-
ing concentrations of tricaine from 300 μM to 1 mM. After
each solution change, the embryo was allowed to equili-
brate with the drug for three minutes prior to imaging.
Stroke volume, heart rate, and cardiac output calculations
Borrowing principles from human ultrasonic Doppler
Imaging, stroke volume and cardiac output were extracted
from linescans of the dorsal aorta close to the heart, where
there is little influence from peripheral vessels. Stroke vol-
ume (SV), the volume of blood ejected by the ventricle in
one heartbeat, was determined by multiplying the cross
sectional area of the aorta (Aaorta.) by the distance blood is
pumped along the aorta in one beat (dx) (Equation 1).
SV = Aaorta × dx (1)
Assuming a circular dorsal aorta, the cross-sectional area is
given by Equation 2, where the diameter of the aorta
(daorta.) was measured from the x-dimension of the per-
pendicular linescan.
A
d
aorta
aorta = ⎛
⎝
⎜
⎞
⎠
⎟ π
2
2
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Because velocity is defined as distance travelled per unit
time, integrating cell velocities as a function of time gives
the distance travelled (Equation 3).
Substitution of Equations 2 and 3 into equation 1 gives
the final equation for stroke volume (Equation 4).
The integral of v(t)dt was approximated by calculating the
area under the curve of a plot of velocity as a function of
time for each heart beat using Origin v.6.0 (Microcal).
Cardiac output, the volume of blood ejected by the heart
in one minute, was calculated by multiplying the stroke
volume by the heart rate (Equation 5).
CO = SV × HR  (5)
Heart rates were determined by dividing 60 seconds by the
average duration of a heart beat, which was measured by
the average peak-to-peak distance of the velocity-versus-
time profile.
Morpholino knockdown of OSM
Morpholino oligonucleotides targeting the translation
initiation site of the Danio rerio ccm2/osm mRNA were pur-
chased from Gene Tools, Inc. Two OSM-specific mor-
pholinos were used (MO#1:
ATCTAATACAGCGAAAATGAAGAGC; MO#2: ATTTG-
TACGTAGAGATGGAGGAGGA). Morpholino sequences
were designed from the +75 to -25 bp region surrounding
the initiating ATG of Danio rerio ccm2/osm cDNA (IMAGE
Clone 7396516) by Gene Tools, Inc. A non-targeting mor-
pholino or 1× Danieau solution (57 mM NaCl, 0.7 mM
KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM HEPES
pH 7.6) were used as controls. Unless otherwise specified,
morpholinos were dissolved to 2 ng/nl in 1× Danieau
solution. Approximately 5 nl of morpholino solution
were injected into embryos between the 1- and 4-cell
stage. Repression of OSM protein was confirmed by
immunoblotting using a rabbit polyclonal anti-OSM anti-
body produced against recombinant full-length mouse
OSM [33].
Capped OSM mRNA synthesis and rescue
Capped, in vitro transcribed ccm2/osm mRNA was synthe-
sized using Mmessage Mmachine T7 kit (Ambion) from
the coding region of a Danio rerio OSM cDNA (IMAGE
Clone 7396516). Embryos between the 1- and 4-cell
stages were injected with 5 nl ccm2/osm mRNA (20–100
pg/nl) together with an OSM morpholino that targets the
5' UTR (MO#1) at 2–4 ng/nl).
In silico microangiography
In  silico  microangiography is an image processing
approach to representing motion in a series of two-
dimensional images. A DIC movie of cells flowing
through the vasculature of anesthetized embryos at 28 or
48 hpf was collected as a set of 100 12-bit tiff images
recorded at 15 ms intervals (X, Y).t. Using Metamorph IP
software (Molecular Devices) a difference image stack was
created by dividing adjacent time points; that is, for time
t = n, Difference.n = (X, Y).n+1. *1000/(X, Y).n.. The result-
ant difference stack has intensity values only where
changes occurred from one time point to the next. Maxi-
mum intensity projections through the differences stack
produce an image correlating to blood cell movement
over the duration of the original movie.
Authors' contributions
MHM and NS conceived of the study. MHM performed
zebrafish husbandry, morpholino knockdown and drug
treatment experiments, acquired images, wrote the laser-
scanning velocimetry data analyzer software, analyzed
linescan images and drafted the manuscript. NS devel-
oped image acquisition protocols, processed images for
linescans, performed in silico microangiography, and
assisted in drafting the manuscript. LS performed
zebrafish husbandry and morpholino knockdown experi-
ments. KH assisted in developing image acquisition pro-
tocols. EL assisted with zebrafish husbandry and
morpholino knockdown experiments. GLJ participated in
the design of the study, coordinated essential collabora-
tions, and assisted in drafting the manuscript. All authors
read and approved the final manuscript.
Additional material
dx v t dt
t
=
′
∫ ()
0
(3)
SV
d
vtd t aorta t
= ⎛
⎝
⎜
⎞
⎠
⎟ ×
′
∫ π
2
2
0 () (4)
Additional File 1
position effects. Dependence of cardiac performance measurements on 
scan line position
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6750-7-40-S1.pdf]
Additional File 2
cardiovascular analysis of OSM morphant. Decreased circulation in 
OSM-deficient embryos only affects the aortic arch
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6750-7-40-S2.pdf]
Additional File 3
restricted circulation movie. Restricted blood flow through constricted 
aortic arch of control and OSM morpholino-injected embryo
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6750-7-40-S3.mov]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Biotechnology 2007, 7:40 http://www.biomedcentral.com/1472-6750/7/40
Page 11 of 11
(page number not for citation purposes)
Acknowledgements
The authors are grateful to Sue Donerly for technical assistance with 
zebrafish husbandry and embryo manipulation. Funding was generously 
provided by the National Institutes of Health to MHM (HL084971) and GLJ 
(GM30324 and GM68820).
References
1. Beis D, Bartman T, Jin SW, Scott IC, D'Amico LA, Ober EA, Verkade
H, Frantsve J, Field HA, Wehman A, Baier H, Tallafuss A, Bally-Cuif L,
Chen JN, Stainier DY, Jungblut B: Genetic and cellular analyses of
zebrafish atrioventricular cushion and valve development.
Development 2005, 132:4193-4204.
2. Chen JN, Haffter P, Odenthal J, Vogelsang E, Brand M, van Eeden FJ,
Furutani-Seiki M, Granato M, Hammerschmidt M, Heisenberg CP,
Jiang YJ, Kane DA, Kelsh RN, Mullins MC, Nusslein-Volhard C: Muta-
tions affecting the cardiovascular system and other internal
organs in zebrafish.  Development 1996, 123:293-302.
3. Warren KS, Wu JC, Pinet F, Fishman MC: The genetic basis of car-
diac function: dissection by zebrafish (Danio rerio) screens.
Philos Trans R Soc Lond B Biol Sci 2000, 355:939-944.
4. Amsterdam A, Hopkins N: Mutagenesis strategies in zebrafish
for identifying genes involved in development and disease.
Trends Genet 2006, 22:473-478.
5. Chen E, Ekker SC: Zebrafish as a genomics research model.
Curr Pharm Biotechnol 2004, 5:409-413.
6. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T,
Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella
M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Mar-
chuk DA: Mutations in a gene encoding a novel protein con-
taining a phosphotyrosine-binding domain cause type 2
cerebral cavernous malformations.  Am J Hum Genet 2003,
73:1459-1464.
7. Sabbah HN, Khaja F, Brymer JF, McFarland TM, Albert DE, Snyder JE,
Goldstein S, Stein PD: Noninvasive evaluation of left ventricular
performance based on peak aortic blood acceleration meas-
ured with a continuous-wave Doppler velocity meter.  Circu-
lation 1986, 74:323-329.
8. DuBourg O, Jondeau G, Beauchet A, Hardy A, Bourdarias JP: Dop-
pler-derived aortic maximal acceleration. A reliable index of
left ventricular systolic function.  Chest 1993, 103:1064-1067.
9. Saeian K, Wann LS, Sagar KB: Doppler echocardiographic evalu-
ation of left ventricular function.  Echocardiography 1990,
7:21-25.
10. Bennett ED, Barclay SA, Davis AL, Mannering D, Mehta N: Ascend-
ing aortic blood velocity and acceleration using Doppler
ultrasound in the assessment of left ventricular function.  Car-
diovasc Res 1984, 18:632-638.
11. Kopp R, Pelster B, Schwerte T: How does blood cell concentra-
tion modulate cardiovascular parameters in developing
zebrafish (Danio rerio)?  Comp Biochem Physiol A Mol Integr Physiol
2006.
12. Bagatto B, Burggren W: A three-dimensional functional assess-
ment of heart and vessel development in the larva of the
zebrafish (Danio rerio).  Physiol Biochem Zool 2006, 79:194-201.
13. Liebling M, Forouhar AS, Wolleschensky R, Zimmermann B, Anker-
hold R, Fraser SE, Gharib M, Dickinson ME: Rapid three-dimen-
sional imaging and analysis of the beating embryonic heart
reveals functional changes during development.  Dev Dyn
2006, 235:2940-2948.
14. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY: Ccm1
is required for arterial morphogenesis: implications for the
etiology of human cavernous malformations.  Development
2004, 131:1437-1448.
15. Schwerte T, Pelster B: Digital motion analysis as a tool for ana-
lysing the shape and performance of the circulatory system
in transparent animals.  J Exp Biol 2000, 203:1659-1669.
16. Kittleson MD, Rienle RD: Aortic Stenosis.  In Small Animal Cardio-
vascular Medicine St. Louis, Mosby, OInc.; 1998:260-272. 
17. Ho YL, Shau YW, Tsai HJ, Lin LC, Huang PJ, Hsieh FJ: Assessment
of zebrafish cardiac performance using Doppler echocardi-
ography and power angiography.  Ultrasound Med Biol 2002,
28:1137-1143.
18. Pan X, Yu H, Shi X, Korzh V, Wohland T: Characterization of flow
direction in microchannels and zebrafish blood vessels by
scanning fluorescence correlation spectroscopy.  J Biomed Opt
2007, 12:14034.
19. Jones EA, Baron MH, Fraser SE, Dickinson ME: Measuring hemody-
namic changes during mammalian development.  Am J Physiol
Heart Circ Physiol 2004, 287:H1561-9.
20. Osterloh K, Gaehtgens P, Pries AR: Determination of microvas-
cular flow pattern formation in vivo.  Am J Physiol Heart Circ Phys-
iol 2000, 278:H1142-52.
21. Zimmerhackl B, Tinsman J, Jamison RL, Robertson CR: Use of dig-
ital cross-correlation for on-line determination of single-ves-
sel blood flow in the mammalian kidney.  Microvascular Research
1985, 30:63-74.
22. Arfors KE, Bergqvist D, Intaglietta M, Westergren B: Measure-
ments of blood flow velocity in the microcirculation.  Ups J
Med Sci 1975, 80:27-33.
23. Jamison RL, Zimmerhackl B, Robertson CR: Videomicroscopic
method for direct determination of blood flow to the papilla
of the kidney.  Ann Biomed Eng 1985, 13:273-280.
24. Fritsche R, Schwerte T, Pelster B: Nitric oxide and vascular reac-
tivity in developing zebrafish, Danio rerio.  Am J Physiol Regul
Integr Comp Physiol 2000, 279:R2200-7.
25. Hou PC, Burggren WW: Cardiac output and peripheral resist-
ance during larval development in the anuran amphibian
Xenopus laevis.  Am J Physiol 1995, 269:R1126-32.
26. Burggren WW, Warburton SJ, Slivkoff MD: Interruption of car-
diac output does not affect short-term growth and meta-
bolic rate in day 3 and 4 chick embryos.  J Exp Biol 2000,
203:3831-3838.
27. Lawson ND, Weinstein BM: In vivo imaging of embryonic vascu-
lar development using transgenic zebrafish.  Dev Biol 2002,
248:307-318.
28. Mably JD, Chuang LP, Serluca FC, Mohideen MA, Chen JN, Fishman
MC: santa and valentine pattern concentric growth of cardiac
myocardium in the zebrafish.  Development 2006,
133:3139-3146.
29. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson
GL, Marchuk DA: CCM1 and CCM2 protein interactions in cell
signaling: implications for cerebral cavernous malformations
pathogenesis.  Hum Mol Genet 2005, 14:2521-2531.
30. Zon LI, Peterson RT: In vivo drug discovery in the zebrafish.
Nat Rev Drug Discov 2005, 4:35-44.
31. Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler
SE, Mohideen MA, Neuhauss SC, Solnica-Krezel L, Schier AF,
Zwartkruis F, Stemple DL, Malicki J, Driever W, Fishman MC: Muta-
tions affecting the formation and function of the cardiovas-
cular system in the zebrafish embryo.  Development 1996,
123:285-292.
32. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M: Design
and validation of a tool for neurite tracing and analysis in flu-
orescence microscopy images.  Cytometry A 2004, 58:167-176.
33. Uhlik MT, Abell AN, Johnson NL, Sun W, Cuevas BD, Lobel-Rice KE,
Horne EA, Dell'Acqua ML, Johnson GL: Rac-MEKK3-MKK3 scaf-
folding for p38 MAPK activation during hyperosmotic shock.
Nat Cell Biol 2003, 5:1104-1110.